Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical science

• Publication date

  2015-10-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1042/CS20140758PMID 25967696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high‐fat‐diet‐fed mice

  2014cited by this paper
• Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.

  2013cited by this paper
• Pathophysiology of Vascular Remodeling in Hypertension

  2013cited by this paper
• Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor

  2012cited by this paper
• Type 2 diabetes mellitus: a review of current trends.

  2012cited by this paper
• Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing

  2012cited by this paper
• Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases.

  2012cited by this paper
• Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report

  2011cited by this paper
• Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects

  2011cited by this paper
• Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation.

  2011cited by this paper
• Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?

  2011cited by this paper
• Mesenteric Resistance Arteries in Type 2 Diabetic db/db Mice Undergo Outward Remodeling

  2011cited by this paper
• Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness

  2011cited by this paper
• IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.

  2011cited by this paper
• IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

  2011cited by this paper
• A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

  2011cited by this paper
• Aldosterone Blockers (Mineralocorticoid Receptor Antagonism) and Potassium‐Sparing Diuretics

  2011cited by this paper
• Small artery remodelling in diabetes

  2010cited by this paper
• Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

  2010cited by this paper
• eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.

  2010cited by this paper
• Angiotensin II Type 1 Receptor-Dependent Oxidative Stress Mediates Endothelial Dysfunction in Type 2 Diabetic Mice

  2010cited by this paper
• Atorvastatin Prevents Angiotensin II–Induced Vascular Remodeling and Oxidative Stress

  2009cited by this paper
• Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism.

  2009cited by this paper
• Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension

  2009cited by this paper
• Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

  2009cited by this paper
• Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

  2008cited by this paper
• Aldosterone and Angiotensin II Synergistically Stimulate Migration in Vascular Smooth Muscle Cells Through c-Src–Regulated Redox-Sensitive RhoA Pathways

  2008cited by this paper
• Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-&ggr;, and Proinflammatory Adipokines

  2008cited by this paper
• Endothelium-Specific GTP Cyclohydrolase I Overexpression Attenuates Blood Pressure Progression in Salt-Sensitive Low-Renin Hypertension

  2008cited by this paper
• The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

  2007cited by this paper
• Endothelial dysfunction in diabetes mellitus

  2007cited by this paper
• Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone.

  2007cited by this paper
• Hyperkalemia.

  2006cited by this paper
• Reactive oxygen species and vascular remodelling in hypertension: still alive.

  2006cited by this paper
• Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats.

  2006cited by this paper
• Diabetes mellitus and its treatment

  2005cited by this paper
• Mechanisms of hypertension: the expanding role of aldosterone.

  2004cited by this paper
• Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy.

  2004cited by this paper
• Stimulation of aldosterone production in vitro and its inhibition by spironolactone

  2004cited by this paper
• Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

  2004cited by this paper
• Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study

  2004cited by this paper
• Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction.

  2004cited by this paper
• Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist.

  2004cited by this paper
• Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling

  2003cited by this paper
• Aldosterone Function in Diabetes Mellitus: Effects on Cardiovascular and Renal Disease

  2003cited by this paper
• Cardiovascular endocrinology 1: aldosterone function in diabetes mellitus: effects on cardiovascular and renal disease.

  2003cited by this paper
• Remodeling of Resistance Vessels in Essential Hypertension

  2003cited by this paper
• Vascular targets of redox signalling in diabetes mellitus

  2002cited by this paper
• Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress

  2002cited by this paper

• The mineralocorticoid receptor: a new chapter for therapeutic regulation of diabetic cardiomyopathy.

  2026cites this paper
• Decoding the role of aldosterone in glycation-induced diabetic complications.

  2024cites this paper
• Eight weeks of treatment with mineralocorticoid receptor blockade does not alter vascular function in individuals with and without type 2 diabetes

  2024cites this paper
• Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ Damage

  2024cites this paper
• Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension

  2023cites this paper
• Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End-organ Damage

  2023cites this paper
• The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice

  2022cites this paper
• Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest

  2021cites this paper
• The Acute Effects of Different Spironolactone Doses on Oxidative Stress in Streptozotocin-Induced Diabetic Rats

  2021cites this paper
• Angiotensin-II activates vascular inflammasome and induces vascular damage.

  2021cites this paper
• Atorvastatina Atenua o Remodelamento Vascular em Camundongos com Síndrome Metabólica

  2021cites this paper
• Eight weeks of mineralocorticoid blockade does not improve insulin sensitivity in type 2 diabetes

  2021cites this paper
• CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1.

  2021cites this paper
• Oxidative Stress and Vascular Damage in the Context of Obesity : The Hidden

  2021cites this paper
• Mineralocorticoids, glucose homeostasis and type 2 diabetes mellitus: The Henan Rural Cohort study.

  2020cites this paper
• Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division

  2020cites this paper
• Role of mineralocorticoid receptor antagonists in kidney diseases

  2020cites this paper
• Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats.

  2019cites this paper
• NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus

  2019cites this paper
• Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress

  2019cites this paper
• Leptin and Aldosterone.

  2019cites this paper
• Aldosterone/MR Signaling, Oxidative Stress, and Vascular Dysfunction

  2019cites this paper
• Mineralocorticoid Receptor and Leptin: A Dangerous Liaison in the Obese Heart

  2019cites this paper
• Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling

  2018cites this paper
• The Role of Renin–Angiotensin–Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging

  2018influential citation
• No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model

  2018cites this paper
• Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness

  2018cites this paper
• Upregulation of Nrf2 and Decreased Redox Signaling Contribute to Renoprotective Effects of Chemerin Receptor Blockade in Diabetic Mice

  2018cites this paper
• Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats

  2018cites this paper
• The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease

  2017cites this paper
• The acute effects of different spironolactone doses on cardiac function in streptozotocin-induced diabetic rats.

  2017cites this paper
• Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets

  2017cites this paper
• Angeli's Salt, a nitroxyl anion donor, reverses endothelin‐1 mediated vascular dysfunction in murine aorta

  2017cites this paper
• Novel insight into the dangerous connection between diabetes and heart failure

  2016cites this paper
• Does Aldosterone Play a Significant Role for Regulation of Vascular Tone?

  2016cites this paper
• Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone

  2016cites this paper
• Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling

  2015cites this paper